7 Eden Park Drive
Level 5
Macquarie Park, NSW 2113
Australia
61 2 8935 9629
https://www.oncosil.com.au
Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno:
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Nigel Lange | CEO, MD & Director | 388,26k | N/D | N/D |
Mr. Christian Dal Cin | CFO & Company Secretary | N/D | N/D | N/D |
Dr. Ralph Peters | Chief Medical Officer | N/D | N/D | N/D |
Mr. David Turner | Head of Medical Affairs | N/D | N/D | N/D |
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
L'ISS Governance QualityScore di OncoSil Medical Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.